Sodium Phosphate, Monobasic, Monohydrate
Generic Name: sodium phosphate, monobasic, monohydrate
Brand Names:
Sodium Phosphates
DESCRIPTION Sodium Phosphates Injection, USP, 3 mmol/mL (millimoles/mL), is a sterile, nonpyrogenic, concentrated solution containing a mixture of monobasic sodium phosphate and dibasic sodium phosphate in Water for Injection. The solution is administered after dilution by the intravenous route as an electrolyte replenisher. It must not be administered undiluted.
Overview
DESCRIPTION Sodium Phosphates Injection, USP, 3 mmol/mL (millimoles/mL), is a sterile, nonpyrogenic, concentrated solution containing a mixture of monobasic sodium phosphate and dibasic sodium phosphate in Water for Injection. The solution is administered after dilution by the intravenous route as an electrolyte replenisher. It must not be administered undiluted.
Uses
INDICATIONS AND USAGE Sodium Phosphates Injection, USP is indicated as a source of phosphate, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. The concomitant amount of sodium (4 mEq/mL) must be calculated into total electrolyte dose of such prepared solutions.
Dosage
DOSAGE AND ADMINISTRATION Sodium Phosphates Injection is administered intravenously only after dilution and thorough mixing in a larger volume of fluid. The dose and rate of administration are dependent upon the individual needs of the patient. Serum sodium, inorganic phosphorus and calcium levels should be monitored as a guide to dosage. Using aseptic technique, all or part of the contents of one or more vials may be added to other intravenous fluids to provide any desired number of millimoles of phosphate and milliequivalents of sodium.
Side Effects
ADVERSE REACTIONS Adverse reactions involve the possibility of phosphate intoxication. Phosphate intoxication results in a reduction of serum calcium and the symptoms are those of hypocalcemic tetany (see WARNINGS ).
Warnings
WARNINGS WARNING: This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum. Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration. Sodium Phosphates Injection must be diluted and thoroughly mixed before use. CONTRAINDICATIONS Sodium phosphate is contraindicated in diseases where high phosphate or low calcium levels may be encountered, and in patients with hypernatremia.
Storage
HOW SUPPLIED Product No. NDC No. Volume 17005PX 63323-170-05 5 mL in a 10 mL vial 17015PX 63323-170-15 15 mL in a 30 mL vial 11850 63323-118-50 50 mL in a 50 mL vial These vials are flip-top, Single Dose Vials, packaged 25 vials per tray. The vials marked with ‘‘PX’’ are partially filled to facilitate transfer of the contents. Do not administer unless solution is clear and seal intact.
Frequently Asked Questions
What is Sodium Phosphate, Monobasic, Monohydrate used for?▼
INDICATIONS AND USAGE Sodium Phosphates Injection, USP is indicated as a source of phosphate, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. The concomitant amount of sodium (4 mEq/mL) must be calculated into total electrolyte dose of such prepared solutions.
What are the side effects of Sodium Phosphate, Monobasic, Monohydrate?▼
ADVERSE REACTIONS Adverse reactions involve the possibility of phosphate intoxication. Phosphate intoxication results in a reduction of serum calcium and the symptoms are those of hypocalcemic tetany (see WARNINGS ).
What are the important warnings for Sodium Phosphate, Monobasic, Monohydrate?▼
WARNINGS WARNING: This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum. Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration. Sodium Phosphates Injection must be diluted and thoroughly mixed before use. CONTRAINDICATIONS Sodium phosphate is contraindicated in diseases where high phosphate or low calcium levels may be encountered, and in patients with hypernatremia.
Related Medications
Ferr Phos, Kali Mur, Kali Sulph, Nat Mur, Nat Sulph
ferr phos, kali mur, kali sulph, nat mur, nat sulph
Uses Temporarily relieves occasional elevated body temperature and the early stages of body stress, including heat, discomfort, redness and swelling.* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE, NOT FDA EVALUATED. This product is not intended to diagnose, treat, cure, or prevent any disease.
Herpes Zoster Nosode
herpes zoster nosode
PURPOSE: Herpes Zoster Nosode - Itching, Tingling, Painful Rash of Body, Rash on Side of Face, Painful Rash on Face
Children Pain Relief
children pain relief
Purpose Pain reliever/fever reducer
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.